Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Amlodipine recalled?

Yes — there is an active recall. 32 ongoing FDA recalls mention Amlodipine (95 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Amlodipine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Amlodipine recalls on record

none so far in 2026; 95 on record, newest first
Class II · Moderate risk

Amlodipine besylate tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation American Health Packaging NDC 68084-506-11 D-1220-2015
Class II · Moderate risk

Amlodipine besylate tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation American Health Packaging NDC 68084-505-11 D-1219-2015
Class II · Moderate risk

Amlodipine besylate tablets

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation American Health Packaging NDC 68084-498-11 D-1218-2015
Class II · Moderate risk

Amlodipine besylate active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-518-2015
Class II · Moderate risk

Amlodipine active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-517-2015
Class III · Low risk

Amlodipine Besylate Tablets

Discoloration: Brown spots were noted embedded in Amlodipine Besylate Tablets, 10 mg, Lot # MP4344.

Terminated Failed specification Zydus Pharmaceuticals USA Inc NDC 68382-123-16 D-0257-2015
Class II · Moderate risk

Tribenzor Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-116-30 D-1504-2014
Class II · Moderate risk

Azor Tablets

Temperature Abuse; various products were not stored at Controlled Room Temperature as per USP guidelines during shipping

Terminated Temperature excursion Daiichi Sankyo Pharma Development NDC 65597-113-30 D-1501-2014
Class II · Moderate risk

Amlodipine Besylate Tablets

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Terminated cGMP deviation Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-452-20 D-1468-2016
Class II · Moderate risk

Amlodipine Besylate Tablets

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Terminated cGMP deviation Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-451-20 D-1467-2016
Class II · Moderate risk

Amlodipine Besylate Tablets

CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Terminated cGMP deviation Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 51079-450-20 D-1466-2016